Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module

Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy

(2013) Qiuling Shi et al.   QUALITY OF LIFE RESEARCH

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy

(2012) Xin Shelley Wang et al.   BRAIN BEHAVIOR AND IMMUNITY

Late dysphagia after radiotherapy-based treatment of head and neck cancer

(2012) Katherine A. Hutcheson et al.   CANCER

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy

(2010) Xin Shelley Wang et al.   BRAIN BEHAVIOR AND IMMUNITY

Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): Searching for Standards

(2010) Charles S. Cleeland et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

The M. D. Anderson Symptom Inventory–Head and Neck Module, a Patient-Reported Outcome Instrument, Accurately Predicts the Severity of Radiation-Induced Mucositis

(2008) David I. Rosenthal et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS